Last updated on March 2019

Ceramide NanoLiposome in Patients With Advanced Solid Tumors

Brief description of study

This study is a dose escalation study of Ceramide NanoLiposome in patients with advanced solid tumors.

Clinical Study Identifier: NCT02834611

Contact Investigators or Research Sites near you

Start Over

Alan Brisendine

Medical University of South Carolina, Hollings Cancer Center
Charleston, SC United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.